|
A UNIT OF THE U-M MEDICAL SCHOOL OFFICE OF RESEARCH
|
New this month
|
 |
|
|
|
EVENT  |
|
DATE |
WHO SHOULD ATTEND |
Startup Roadshow - AI in Healthcare
 |
 |
Thursday,
January 24, 2019
8:45am-12:00pm
Biomedical Science Research Building (BSRB)
Kahn Auditorium
Entrepreneur Office Hours to follow from 12:30pm-2:30pm
CLICK HERE to learn more and register. U-M faculty and staff attend for FREE! (Discount code available on website.) |
Entrepreneurs and experienced developers of artificial intelligence for the health care industry can attend this unique program that provides an overview on a wide range of topics relating to AI in healthcare, including a panel discussion featuring Tom Shehab, M.D., Managing Partner, Arboretum Ventures, and Don Bauman, CEO, Isabel Healthcare.
Following the main session, Entrepreneur Office Hours will be available from 12:30pm-2:30pm (sign up available during the program's 11:00am break) to learn more about the following: "Is my software regulated?" and "What is my best pitch to market? (and other questions associated with regulated software)". |
|
Congratulations to the U-M Therapeutic Fund Awardees
Three projects selected for funding from a highly competitive field
 The Michigan Center for Therapeutic Innovation (MCTI) and FFMI recently awarded funding for three projects through the U-M Therapeutic Fund, a 5-year, $2.5M fund created to accelerate the discovery and translation of therapeutic candidates at the University of Michigan. An advisory committee of recognized drug discovery and development experts from industry and academia reviewed and selected projects for funding.
U-M Therapeutic Fund awardees for 2018:
| Name |
Department |
Project Title
|
| Liangyou Rui |
Molecular & Integrative Physiology |
Developing novel kinase inhibitors for NASH treatment |
| Matthew Soellner, Sofia Merajver, and Sameer Phadke |
Internal Medicine - Hematology/Oncology |
Development of dual inhibitors for the treatment of triple negative breast cancer |
| James Varani |
Pathology |
SAR studies on novel, non-irritating retinoids |
The fund supports the discovery and optimization of small molecule lead compounds for projects with a specific, novel, and testable drug discovery hypothesis. Selected projects receive funding and resources to support medicinal chemistry efforts through MCTI and funding for drug design, assay development, cell biology, structural biology, and pharmacology (up to $150,000 in value for each award for a period of 18 months, with the funds being dispersed in two stages). The fund is jointly administered by MCTI and FFMI.
|
Next Round for Mi-TRAC for Life Sciences Proposals Due February 1
Mid-stage funding for biomedical innovation
 Have a hot concept in the realm of biomedical devices, diagnostics, therapeutics, or digital health/IT that would be a great candidate for commercialization?
Mi-TRAC Awards are part of the MTRAC for Life Sciences Innovation Hub. Made possible by the Michigan Economic Development Corporation, and co-managed by FFMI and the U-M Office of Technology Transfer, the awards provide mid-stage, translational research funding and resources for proof-of-concept and late-stage translational studies with a high potential of commercial success. We're excited to kick off the third year of this statewide research innovation and commercialization program with the recent renewal of funding from the MEDC.
Innovators from all schools at the University of Michigan, other institutions of higher education, non-profit research centers, and hospital systems across Michigan are eligible to submit projects for funding consideration.
|
Proposals due Monday, September 24
|
Questions? Contact Sara Johnson, Ph.D., Biomedical Innovation Specialist, at [email protected] or 734-764-5598.
|
9th Cohort of FFMI
fastPACE Course Wraps Up
Biomedical commercialization course awards winning teams
 |
|
|
Peter Freddolino, Ph.D., Therapeutics
and Crowd Favorite winner, receives his award from Brad Martin, Ph.D., FFMI Senior Director of Commercialization Programs, and Sara Johnson, Ph.D., Biomedical Innovation Specialist
|
Fast Forward Medical Innovation recently ended the ninth cohort of the
FFMI fastPACE Course, with a competition in which teams from the University of Michigan, Eastern Michigan University, Western Michigan University, Henry Ford Health System, and the 2018 winners of the Madonna University/Detroit/Windsor Hacking Health event pitched their projects to the class and a panel of judges. Fifteen project teams graduated from the 4-week program that is designed to provide the knowledge and tools needed to navigate the initial process of innovation and commercialization.
Congratulations to the winning project teams!
|
Device/Diagnostics:
Phillip Olla, Ph.D. Professor and Director of Center for Research, Madonna University
Vickee Le, Student
Samuel Yang, Web Development
Briana Mozariwskyj, Student
Madonna University/Detroit/Windsor Hacking Health 2018 Winner
Cognizance - Cannabis Impairment Detection Platform
Health IT:
Akbar Waljee, M.D., Associate Professor, Internal Med- Gastroenterology
Adish Parikh, Medical Student
John Seamans, M.S.E., Clinical Engineering Director, Delphinus Medical Technologies
University of Michigan
Machine learning algorithm for optimizing IBD treatment
Therapeutics and Crowd Favorite Award Winner:
Peter Freddolino, Ph.D., Assistant Professor, Biological Chemistry and Computational Medicine
Mehdi Rahimpour, Ph.D., Research Fellow, Biological Chemistry
Michael Schmidt, Graduate Student, Biological Chemistry
University of Michigan
Novel target for preventing biofilm formation
|
|
Yannis Paulus, M.D., F.A.C.S., co-PI on an
MTRAC award-winning project, has been recognized by major news channels around the world for his publication about a forceful chiropractic technique on a person's necks that may cause ruptures in the eyes' blood vessels.
CLICK HERE to read the full article.
|
In Other News
The UM Coulter Translational Research Partnership Program is pleased to announce the 2019 Call for Proposals. The Coulter Program funds collaborative translational research projects between Engineering and Clinical faculty co-investigators, with the goal of accelerating development and commercialization of new medical devices, diagnostics, and other medical product concepts that address unmet clinical needs and lead to improvements in healthcare. The deadline for proposal submissions is February 4, 2019. Coulter funding does not require a departmental funding match.
CLICK HERE
for more details.
The Michigan Center for Integrative Research in Critical Care (MCIRCC) is currently accepting applications for the K12 Career Development Program in emergency critical care research. This three-year, multidisciplinary training program offers junior faculty and graduating fellows the chance to work with mentoring teams to gain an understanding of all phases of emergency critical care research.
CLICK HERE to learn more.
Save the Date!
The MCIRCC 2019 Grand Challenge Kickoff event is February 22, 2019. A generous gift from the Joyce and Don Massey Family Foundation is funding the development of solutions to address severe traumatic brain injury. The keynote speaker is Rockefeller Oteng, M.D., Assistant Professor, U-M Emergency Medicine. Bring your innovative ideas or come to be inspired!
CLICK HERE to learn more.
|
|
|
|
|
|
|
|
(734) 615-5060
